[1]JournalofMedicinalChemistry,2012,vol.55,p.4764-4775
[2]Patent:WO2013/36676,2013,A1.Locationinpatent:Paragraph0289-0290;0293-0294
[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.529-541
10254-89-4
138385-04-3
7146-67-0
21447-56-3
6339-26-0
918812-18-7
79037-25-5 | CORTISOL-1,2-D2 | AA00G3E7 | MFCD00190408
847950-09-8 | Lck Inhibitor | AA00G3M3 | MFCD18782603
84160-41-8 | 2-((5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetic acid | AA00G3QE | MFCD02741510
854357-30-5 | ETHYL 5-AMINO-4-(AMINOCARBONYL)-2-METHYL-3-FUROATE | AA00G3UE | MFCD06655901
827614-58-4 | N-Benzyl-2-piperazin-1-ylacetamide | AA00G43L | MFCD04115628
81328-51-0 | 3,5-Dimethyl-4-propyl-1h-pyrazole | AA00G4E0 | MFCD00964165
842974-84-9 | 3-Chloro-6-(2-hydroxyethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid | AA00G4JI | MFCD06589852
79299-77-7 | 9-cis-Retinyl Stearate | AA00G4PE | MFCD31563337
7709-13-9 | 4-Chloro-1,3,5-triazin-2-amine | AA00G4WJ | MFCD19203794
80279-24-9 | tilivalline | AA00G549